Source:http://linkedlifedata.com/resource/pubmed/id/15240151
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions |
umls-concept:C0007634,
umls-concept:C0021753,
umls-concept:C0033634,
umls-concept:C0041904,
umls-concept:C0044602,
umls-concept:C0079904,
umls-concept:C0086418,
umls-concept:C0162493,
umls-concept:C0285761,
umls-concept:C1120843,
umls-concept:C1150481,
umls-concept:C1150587,
umls-concept:C1314939,
umls-concept:C1367731,
umls-concept:C1368105,
umls-concept:C1451005,
umls-concept:C1705325,
umls-concept:C1705632
|
pubmed:issue |
3
|
pubmed:dateCreated |
2004-7-8
|
pubmed:abstractText |
Induction of human beta-defensin 2 (HBD-2) by interleukin-1beta (IL-1beta) in epithelial cells has been reported. However, the mechanism by which IL-1beta up-regulates HBD-2 remains poorly understood. In this study, we investigated the effect of IL-1beta on induction of HBD-2 in A549 cells. IL-1beta markedly increased HBD-2 mRNA expression in concentration- and time-dependent manners. HBD-2 mRNA expression in response to IL-1beta was attenuated by pretreatment of GF109203X, Go6976, and staurosporine [inhibitors of protein kinase C (PKC)], SB203580 [an inhibitor of p38 mitogen-activated protein kinase (MAPK)], SP600125 [an inhibitor of c-Jun N-terminal kinase (JNK)], and LY294002 [an inhibitor of phosphatidylinositol-3-kinase (PI3K)], but not PD98059 [an inhibitor of extracellular signal-regulated kinase (ERK)], suggesting involvement of PKC, p38 MAPK, JNK, and PI3K in this response. Interestingly, IL-1beta induced nuclear factor-kappaB (NF-kappaB) activation in A549 cells, which was shown by increased nuclear translocation of p65 NF-kappaB and degradation of IkappaB-alpha. Importantly, IL-1beta-induced HBD-2 mRNA expression was inhibited by blockage of NF-kappaB activation using NF-kappaB inhibitors, including pyrrolidine dithiocarbamate and MG132. Specifically, IL-1beta-induced nuclear translocation of NF-kappaB was in part attenuated by LY294002, but not by GF109203X, SB203580, and SP600125, suggesting PI3K-dependent nuclear translocation of NF-kappaB in response to IL-1beta. Together, these results suggest that IL-1beta induces HBD-2 mRNA expression in A549 cells, and the induction seems to be at least in part mediated through activation of NF-kappaB transcription factor as well as activation of signaling proteins of PKC, p38 MAPK, JNK, and PI3K, but not ERK.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/DEFB4A protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/Interleukin-1,
http://linkedlifedata.com/resource/pubmed/chemical/NF-kappa B,
http://linkedlifedata.com/resource/pubmed/chemical/Phosphotransferases,
http://linkedlifedata.com/resource/pubmed/chemical/beta-Defensins
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jul
|
pubmed:issn |
0006-291X
|
pubmed:author |
pubmed-author:BaekWon-KiWK,
pubmed-author:ChoJae-WeJW,
pubmed-author:JangByeong-ChurlBC,
pubmed-author:JungTae-YoungTY,
pubmed-author:KimSang-ChanSC,
pubmed-author:KimSang-PyoSP,
pubmed-author:KwonTaeg KyuTK,
pubmed-author:KwonYoung-KyuYK,
pubmed-author:LimKi-JoKJ,
pubmed-author:PaikJi-HyeJH,
pubmed-author:ShinSang-WooSW,
pubmed-author:SuhMin-HoMH,
pubmed-author:SuhSeong-IlSI
|
pubmed:issnType |
Print
|
pubmed:day |
30
|
pubmed:volume |
320
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1026-33
|
pubmed:dateRevised |
2010-9-17
|
pubmed:meshHeading |
pubmed-meshheading:15240151-Adenocarcinoma,
pubmed-meshheading:15240151-Cell Line, Tumor,
pubmed-meshheading:15240151-Humans,
pubmed-meshheading:15240151-Interleukin-1,
pubmed-meshheading:15240151-NF-kappa B,
pubmed-meshheading:15240151-Phosphotransferases,
pubmed-meshheading:15240151-Up-Regulation,
pubmed-meshheading:15240151-beta-Defensins
|
pubmed:year |
2004
|
pubmed:articleTitle |
Up-regulation of human beta-defensin 2 by interleukin-1beta in A549 cells: involvement of PI3K, PKC, p38 MAPK, JNK, and NF-kappaB.
|
pubmed:affiliation |
Department of Microbiology, Chronic Disease Research Center, Institute for Medical Science, School of Medicine, Keimyung University, #194 DongSan-Dong Jung-Gu, Daegu 700-712, Republic of Korea.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|